Pharma firm in Canadian ginseng deal
Print Edition
SHANGHAI Pharmaceutical Holdings Shenxiang Health Medicine Co said yesterday it has entered into a strategic partnership with Northland Ginseng Farms in Ontario, Canada, to set up a planting site for ginseng.
Shanghai Shenxiang will procure raw material directly from the standardized planting site at Northland Ginseng Farms and provide growing standards and guidance so that they can meet local food and drug standards.
It’s also an important step towards the company carrying out its blueprint of setting up planting sites near the source of raw materials to ensure quality.
Chairman of Shanghai Pharmaceutical Shenxiang and general manager of Shanghai Traditional Chinese Medicine Co Yu Weidong said this is the latest move for Shanghai Pharma to grab opportunities presented by China’s trillion dollar Belt and Road Initiative to shore up its raw material supplies.
The total amount of sourcing would represent about 50 million yuan (US$7.5 million) of annual retail sales at Shanghai Pharma Shenxiang.
It will also continue to push forward sustainable manufacturing and sourcing by collaborating with other potential overseas planting sites.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
